BeyondSpring Inc. 8-K

What Happened BeyondSpring Inc. filed a Form 8-K on June 4, 2026, announcing leadership changes effective July 1, 2026. Dr. Lan Huang will transition from her role as Chief Executive Officer effective July 1, 2026, and will continue as Chair of the Board. Mr. Min Qiu will become Chief Executive Officer and Ms. Na Li will become Chief Financial Officer, both effective July 1, 2026. The company issued a press release on June 4, 2026, describing these changes.

Key Details

• Dr. Lan Huang will forfeit all unvested equity and long‑term incentive awards effective July 1, 2026.
• Min Qiu (appointed CEO) has been involved in the company’s corporate development through its subsidiary Wanchunbulin and holds a B.Pharm and an M.Eng. from the University of Tokyo.
• Na Li (appointed CFO) has been CFO of Wanchunbulin since November 2020 and holds accounting and board secretary qualifications.
• Dr. Jiangwen Majeti was appointed Vice Chair of the Board and received a one‑time grant of options to purchase 100,000 ordinary shares, vesting in four equal annual installments under the company’s 2017 Omnibus Incentive Plan.
• Employment/compensation agreements for Mr. Qiu and Ms. Li have not been finalized; the company will file an amendment to the 8-K to disclose those arrangements within four business days after they are determined.

Why It Matters Executive leadership changes can affect strategic direction, operational execution and investor sentiment. Key facts for shareholders: the outgoing CEO will remain as Chair (providing some continuity), unvested awards held by the outgoing CEO will be forfeited (affecting potential future dilution), and new CEO/CFO compensation terms have not yet been disclosed (watch for the forthcoming 8-K amendment). Investors should monitor the company’s next filings and any guidance or operational updates tied to the leadership transition.